Every Cancer Journey is Unique.

It Should be Guided by Real Data.

THE APPROACH

THE CANFREE™ APPROACH TO CANCER

We know that a cancer diagnosis can be overwhelming, leaving you with more questions than answers.
You are looking for clarity in the confusion, hope in the uncertainty, and a team you can trust to see you, not just your disease.
At Oritov, we use liquid biopsy in Singapore alongside the CANFREE™ Approach to Cancer to replace uncertainty with the clarity of real data, to support you with a personalised path forward, and to empower you with the knowledge to navigate your path with confidence — so that you can make informed decisions with your medical team.
WHAT IS CANFREE™
C

Clarity through Comprehensive Cellular Analysis

Explains

Combining standard diagnostics — PET/CT, tissue biopsy — with real-time liquid biopsy analysis, for a fuller picture of your tumour's biology.

The Outcome

You and your medical team gain an objective, 360-degree understanding of your disease, supporting more informed discussions.

N

Navigated by Empowered Clinical Experts

Explains

Educational resources on liquid biopsy, cellular analysis, and metabolic nutrition, from our registered medical professionals.

The Outcome

Scientific resources give your medical team greater confidence navigating complex, data-guided clinical decisions.

At Oritov,
we use the CANFREE™ APPROACH TO CANCER to replace uncertainty with the clarity of real data.

A

Adaptive & Personalized Action Plans

Explains

Combining standard diagnostics with real-time liquid biopsy analysis — so your supportive strategy adapts as your biology changes over time.

The Outcome

Precise cellular data gives your medical team a clearer basis for supportive strategies shaped to your tumour's biology.

R

Real Data to Guide Decisions

Explains

Liquid biopsy tests monitor circulating tumour cells & cancer stem cells — an added layer alongside standard imaging.

The Outcome

Real-time cellular data supports informed treatment discussions — rather than waiting months for changes to show on a scan.

E

Empowerment Through a Global Clinical Ecosystem

Explains

We connect you to global oncology research, precision laboratories, and data tools — beyond limited local resources.

The Outcome

Comprehensive scientific information gives you the confidence to actively partner with your medical team and advocate for your care.

F

Fueling Metabolic Resilience

Explains

Cancer alters cellular metabolism — we support that with evidence-based nutritional strategies for cellular health.

The Outcome

Supporting your overall wellbeing and physical resilience, to help you stay prepared throughout treatment.

E

Evidence-Based Synergistic Integration

Explains

Peer-reviewed evidence, like testing Berberine against your specific cancer cells, to see what complements treatment.

The Outcome

An evidence-informed integrative approach that helps identify potential drug–supplement interactions across your available therapies.

APPROACH 1

Liquid Biopsy in Singapore

Beyond the Tumour

Standard imaging and tissue biopsies are essential — but they capture a single moment in time. Cancer is dynamic and constantly evolving.
Liquid biopsy provides additional biological information by analysing Circulating Tumour Cells (CTCs), complementing standard diagnostics with insights they cannot provide on their own. Oritov coordinates access to this testing pathway through registered medical partners in Singapore.

THE RESULT

Hover to see it come together.
Clarity
Biological
Informed
Clinical
Discussions
Support

Liquid Biopsy

Bringing Clarity to Your Cancer Biology

Beyond the Tumour

Understand how your cancer may be behaving beyond the primary tumour site

Living Cell Response

Understand how your living cancer cells may respond to different therapies in the laboratory

Sharper Clarity

Build a clearer, more complete biological picture to guide treatment discussions with greater confidence

APPROACH 2

METABOLIC NUTRITION

Nutritional Strategies

Cancer does not just affect the tumour – it influences your body’s cellular metabolism, immune environment, and overall biological resilience.

While your medical team addresses the disease directly, your body’s ability to stay strong throughout treatment matters just as much.

Metabolic nutrition provides evidence-based nutritional strategies to support your body from within — informed by your biological information, not generic advice.

THE RESULT

Hover to see it come together.
NUTRITIONAL STRATEGIES
METABOLIC HEALTH
EVIDENCE-INFORMED

Metabolic Nutrition

Fuelling Your Body's Resiliency

Nutritional Strategies

Develop more personalised nutritional strategies informed by your biological information

Metabolic Health

Support your overall wellbeing, metabolic health, and physical resilience during active treatment

Evidence-informed

Provide evidence-informed nutritional and supplementation strategies that complement your standard medical care

APPROACH 3

CLINICAL EXPERT NETWORK

Biological Insight

Having the right data and nutritional strategies means little without the right people to act on them.

The CANFREE™ APPROACH TO CANCER framework is built on the belief that an empowered, well-equipped medical team is your greatest asset in navigating cancer.

We work alongside your medical team, empowering them with additional biological information, evidence-informed resources, and educational support to facilitate more informed care discussions.

THE RESULT

Hover to see it come together.
Empowering
Medical
Team
Serve
You
Better

Clinical Expert Network

Empowering Your Medical Team to Serve You Better

Biological Insight

Insights that provide additional biological information to support clinical discussions

Evidence-Based

Evidence-based metabolic nutrition protocols informed by your biological information

Access to Specialists

Access to a growing network of practitioners trained in the CANFREE™ APPROACH TO CANCER Framework

APPROACH 4

A Collaborative Approach to Your Care

Partnering

THE RESULT

Hover to see it come together.

Partnering With Your Medical Team

Supporting More Informed Conversations About Your Care

At Oritov, we work in partnership with your medical team.
By providing additional biological information through liquid biopsy and evidence-informed metabolic nutrition strategies, we equip your medical team with a more complete picture — supporting more informed, personalised discussions about your care alongside your standard treatment.

Continue Your Journey

Your cancer journey is unique.

Whether you want to better understand the CANFREE™ APPROACH TO CANCER, explore Liquid Biopsy, or learn more about Metabolic Nutrition, our educational resources are here to support you as you continue your journey.
FREQUENTLY ASKED QUESTIONS

The CANFREE™ APPROACH TO CANCER is Oritov’s educational approach to helping patients and families better understand cancer as a broader biological picture. It brings together education on topics such as Liquid Biopsy, Metabolic Nutrition, and patient navigation to support more informed discussions with your medical team.

No. Liquid Biopsy is designed to complement—not replace—standard tissue biopsy, hospital investigations, or treatment recommended by your medical team. Any clinical decisions remain with your medical team.

Oritov provides education, helps patients better understand complex cancer topics, and, where appropriate, coordinates access to clinician-directed laboratory testing pathways. Our role is to support understanding alongside your standard medical care—not replace it.

The CANFREE™ APPROACH TO CANCER recognises that cancer affects more than a single tumour. Researchers continue to study metabolism, nutrition, and cellular health in the context of cancer. Oritov provides educational resources to help patients better understand these topics alongside conventional cancer care.

You can begin by exploring our educational resources, downloading the CANFREE™ APPROACH TO CANCER Guide, or speaking with our team. If clinician-directed laboratory testing is appropriate for your situation, we can explain the process and help coordinate with your medical team where appropriate.

Download

The CANFREE™ Approach to Cancer Guide Download

CLINICAL LITERATURE CITATIONS

Study: Winther, H., et al. (2020). “Multidisciplinary treatment of unresectable colorectal liver metastases (CRCLM) using liquid biopsy precision oncotherapy in selecting drugs in comparison to tissue biopsy.” Journal of Cancer Research and Clinical Oncology.

Study: Papasotiriou, I., et al. (2015). “Circulating tumor cells isolation and characterization in many cancer types: An alternative fluidic-based method.” Journal of Cancer Therapy.

Study: Maier, T., Serrano, L., et al. (2009). “Correlation of mRNA and protein in complex biological samples.” Nature FEBS Letters.

Study: Friberg, S., & Mattson, S. (1997). “On the growth rates of human malignant tumors.” Journal of Surgical Oncology.

DISCLAIMER